UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is daily supervised buprenorphine-naloxone dosing necessary?

BMJ (Online), 2022-08, p.e071467

2022

Volltextzugriff (PDF)

Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder

Drug and alcohol dependence, 2019-12, Vol.205, p.107612-107612, Article 107612

2019

Volltextzugriff (PDF)

Craving and opioid use disorder: A scoping review

Drug and alcohol dependence, 2019-12, Vol.205, p.107639-107639, Article 107639

2019

Volltextzugriff (PDF)

Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder

Drug and alcohol dependence, 2020-08, Vol.213, p.108122-108122, Article 108122

2020

Volltextzugriff (PDF)

Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic

The American journal on addictions, 2021-09, Vol.30 (5), p.445-452

2021

Volltextzugriff (PDF)

Developing a remotely delivered intensive outpatient program adapted for hospitalized patients with opioid use disorder: A qualitative study

Addictive behaviors reports, 2024-06, Vol.19, p.100546-100546, Article 100546

2024

Volltextzugriff (PDF)

Multiple imputation for non-monotone missing not at random data using the no self-censoring model

Statistical methods in medical research, 2023-10, Vol.32 (10), p.1973-1993

2023

Volltextzugriff (PDF)

Do People with Opioid Use Disorder and Posttraumatic Stress Disorder Benefit from Adding Individual Opioid Drug Counseling to Buprenorphine?

Drug and alcohol dependence, 2021-09, Vol.228, p.109084-109084

2021

Volltextzugriff (PDF)

Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain

The American journal of drug and alcohol abuse, 2019-09, Vol.45 (5), p.488-494

2019

Volltextzugriff (PDF)

Assessment of the Short Grit Scale in patients with substance use disorder: Psychometric properties and patient characteristics

The American journal of drug and alcohol abuse, 2023-07, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Volltextzugriff (PDF)

Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients

The American journal on addictions, 2024-11, Vol.33 (6), p.631-640

2024

Volltextzugriff (PDF)

Review: Adjunctive pharmacologic approaches for benzodiazepine tapers

Drug and alcohol dependence, 2018-08, Vol.189, p.96-107

2018

Volltextzugriff (PDF)

Statistical considerations in the choice of endpoint for drug use disorder trials

Drug and alcohol dependence, 2017-12, Vol.181, p.219-222

2017

Volltextzugriff (PDF)

Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use

The American journal on addictions, 2018-09, Vol.27 (6), p.485-490

2018

Volltextzugriff (PDF)

Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

Frontiers in psychiatry, 2023-03, Vol.14, p.1155984

2023

Volltextzugriff (PDF)

Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders

Drug and alcohol dependence, 2019-12, Vol.205, p.107644-107644, Article 107644

2019

Volltextzugriff (PDF)

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder

Drug and alcohol dependence reports, 2024-06, Vol.11, p.100226-100226, Article 100226

2024

Volltextzugriff (PDF)

A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial

Journal of addiction medicine, 2023-09, Vol.17 (5), p.604-607

2023

Volltextzugriff (PDF)

Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study

Integrative medicine reports, 2022-08, Vol.1 (1), p.157-163

2022

Volltextzugriff (PDF)

Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial

Drug and alcohol dependence, 2024-06, Vol.259, p.111286, Article 111286

2024

Volltextzugriff (PDF)

Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders

Substance use & misuse, 2021, Vol.56 (1), p.87-92

2021

Volltextzugriff (PDF)

Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting

Behavior therapy, 2021-07, Vol.52 (4), p.897-906

2021

Volltextzugriff (PDF)

Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder

Drug and alcohol dependence, 2019-12, Vol.205, p.107675-107675, Article 107675

2019

Volltextzugriff (PDF)

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Contemporary clinical trials, 2024-07, Vol.142, p.107543, Article 107543

2024

Volltextzugriff (PDF)

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Addiction science & clinical practice, 2021-03, Vol.16 (1), p.15-15, Article 15

2021

Volltextzugriff (PDF)

1 – 25 von 596

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(460)
Mit Volltextzugriff
(507)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(189)
Life Sciences & Biomedicine
(106)
Physical Sciences
(59)
Social Sciences
(45)
Psychiatry
(43)
Technology
(39)
Psychology
(29)
Substance Abuse
(29)
Biological And Medical Sciences
(27)
Engineering
(23)
Medical Sciences
(22)
Paleomagnetism
(21)
Human
(20)
Substance Use Disorder
(18)
Chemistry
(17)
Magnetic Fields
(17)
Engineering, Electrical & Electronic
(16)
Drug Addiction
(15)
Science & Technology - Other Topics
(15)
Magnetization
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Is daily supervised buprenorphine-naloxone dosing necessary?

Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder

Craving and opioid use disorder: A scoping review

Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder

Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic

Developing a remotely delivered intensive outpatient program adapted for hospitalized patients with opioid use disorder: A qualitative study

Multiple imputation for non-monotone missing not at random data using the no self-censoring model

Do People with Opioid Use Disorder and Posttraumatic Stress Disorder Benefit from Adding Individual Opioid Drug Counseling to Buprenorphine?

Associations between pain catastrophizing and clinical characteristics in adults with substance use disorders and co-occurring chronic pain

Assessment of the Short Grit Scale in patients with substance use disorder: Psychometric properties and patient characteristics

Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients

Review: Adjunctive pharmacologic approaches for benzodiazepine tapers

Statistical considerations in the choice of endpoint for drug use disorder trials

Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use

Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder

A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial

Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study

Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial

Associations between Childhood Abuse and Chronic Pain in Adults with Substance Use Disorders

Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting

Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder

Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)"

Aktive Filter

Suchergebnisse filtern